Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Therapeutic peptides: current applications and future directions
Contact your clinical team promptly if you experience: Persistent vomiting that prevents you from keeping food or fluids down for more than 24 hours Signs of dehydration including dark urine, dizziness, dry mouth, or significantly reduced urine output Unexplained or severe abdominal pain, which may rarely indicate pancreatitis a serious but recognised risk with GLP-1based therapies [21] [22] Persistent pain in the upper right side of your abdomen, particularly if accompanied by fever, jaundice (yellowing of the skin or whites of the eyes), pale stools, or dark urine these may be signs of gallbladder disease, which can occur with rapid weight loss and with GLP-1based medicines, and requires prompt assessment [20] Unintentional weight loss that feels excessive or rapid beyond what has been discussed as a treatment goal Symptoms suggestive of nutritional deficiency, such as persistent fatigue, hair thinning, muscle weakness, or low mood It is also advisable to seek a dietitian referral early in treatment, ideally before starting retatrutide or during the initial dose escalation phase
Because it is a stimulant and a Schedule IV controlled substance, phentermine is generally only recommended for short-term use
Thus, it could be expected that CR, CHO restriction or other fasting mimicking diets 172 could be effective against tumor growth in humans
